Filter
242
Text search:
FDC
Featured
Recommendations
38
New Publications
87
Language
Document type
No document type
189
Guidelines
20
Studies & Reports
17
Training Material
5
Manuals
4
Fact sheets
4
Situation Updates
1
Resource Platforms
1
Strategic & Response Plan
1
Countries / Regions
India
18
Tanzania
12
Kenya
10
South Africa
10
Malawi
8
Namibia
8
Ghana
5
Uganda
5
Zambia
5
Indonesia
5
Bangladesh
5
Burkina Faso
4
Nigeria
4
Ethiopia
4
Zimbabwe
4
Nepal
4
Cambodia
4
Philippines
3
Sierra Leone
2
Mozambique
2
Eswatini/ Swaziland
2
Botswana
2
Myanmar / Burma
2
Latin America and the Carribbean
2
Global
2
Liberia
1
Senegal
1
Congo, Democratic Republic of
1
Cameroon
1
Pakistan
1
Afghanistan
1
Gambia
1
Rwanda
1
Madagascar
1
Lesotho
1
Sri Lanka
1
South–East Asia Region
1
Western and Central Europe
1
Bhutan
1
Albania
1
Timor Leste/ East Timor
1
Tajikistan
1
Gabon
1
Authors & Publishers
Publication Years
Category
Countries
126
Clinical Guidelines
39
Public Health
6
Pharmacy & Technologies
6
Capacity Building
3
Key Resources
2
Toolboxes
TB
60
HIV
41
AMR
14
Pharmacy
8
NCDs
3
Polio
2
Refugee
2
NTDs
2
Specific Hazards
1
Global Health Education
1
COVID-19
1
htb supplement: 2018 Vol 19:(1)
New drugs in development
July 2018
www.i-Base.info
Accessed 7 July 2015
Three Years After Enactment of the Drug Quality and Security Act
PlosOne January 20, 2021
https://doi.org/10.1371/journal.pone.0241899
Antibiotic fixed dose combinations (FDCs) can have clinical advantages such as improving effectiveness and adherence to therapy. However, high use of potentially inappropriate FDCs has been reported, with implications for antim
...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
TB treatment for children is fundamentally the same as for adults, with a combination of TB drugs needing to be taken for a number of months. TB treatment for children consists of an intensive phase followed by a continuation phase. The purpose of the intensive phase is to rapidly eliminate the majo
...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Downloaded from https://aidsinfo.nih.gov/guidelines on 10/19/2019
Developed by the HHS Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV—A Working Group of the Office
of AIDS Research Advisory Council (OARAC)
Accessed 25th March 2015
Malawi Integrated Guidelines and Standard Operating Procedures for Providing HIV Services. 3rd edition 2016
This document is written for medical doctors, clinical officers, medical assistants, nurses, midwives, health surveillance assistants (HSAs), and medical records clerks who are working in public and private sector health facilities in Malawi. It is designed to be a practical guide for implementation
...
Vol. 2: Clinicians' Guide
Clinicians’ Guide is designed to assist busy medical practitioners in the field with patient management by providing current, essential, practical guidance and background, packaged into a single resource
Clinicians’ Guide is designed to assist busy medical practitioners in the field with patient management by providing current, essential, practical guidance and background, packaged into a single resource
Guidelines for treatment of drug-susceptible tuberculosis and patient care
2017 update
